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A B S T R A C T
Background: Dementia is considered to be a highly stigmatized condition leading to signiﬁcant negative eﬀects
on the health and well-being of people with dementia and people supporting someone living with dementia.
Even though there has been an increasing amount of research on dementia-related stigma over the past two
decades, research on eﬀective, evidence-based approaches to reduce dementia-related public stigma is still
lacking.
Methods: A 2 × 2 factorial randomized controlled trial (RCT) is being conducted to evaluate the feasibility and
short-term eﬃcacy of an online intervention program. It compares diﬀerent approaches to reduce dementia-
related public stigma: 1) Education (ED) that is designed to provide written information on dementia; 2) Contact
(CT) that is designed to oﬀer indirect virtual contact with people with dementia and/or people supporting
someone with dementia; 3) Education plus contact (ED + CT) that is designed to provide both written in-
formation on dementia and indirect virtual contact with people with dementia and/or people supporting
someone living with dementia; and 4) an active control condition receiving written information on general
health. We aim to recruit 500 lay persons aged 40 and over, to complete a questionnaire measuring the level of
dementia-related public stigma, assessed with a modiﬁed Attribution Questionnaire and dementia knowledge,
assessed with the Dementia Knowledge Assessment Scale version 2 at baseline and follow-up assessments (im-
mediately after the intervention and 12 weeks post-intervention).
Discussion: Results from this trial will provide evidence on the most eﬀective approach in reducing dementia-
related public stigma. The results are also likely to form an evidence base for the feasibility of dementia-related
public stigma campaigns to educate the general public.
1. Introduction
People living with dementia (PWD) and people supporting someone
with dementia are often stigmatized, where stigma is deﬁned as an
attribute that is deeply discrediting within a social interaction [1],
which may lead to labeling, stereotyping, separation, status loss, and
discrimination [2]. Dementia-related stigma is due to fear and lack of
awareness and understanding about the disease [3]. Dementia-related
stigma can cause signiﬁcant negative eﬀects such as low self-esteem,
isolation, poor mental health, decreased quality of life in PWD and
increased negative impact of supporting someone with dementia [4–6].
The stigma associated with dementia has been highlighted as the
number one concern for people living with the disease and people
supporting someone living with dementia worldwide [4,7]. It has also
been identiﬁed as one of the most important factors contributing to the
avoidance of help-seeking behaviors [8,9] therefore, delaying the di-
agnosis and the utilization of health and social services [10].
There has been a growing amount of research on dementia-related
stigma over the past two decades including two recent systematic re-
views [11,12] examining diﬀerent types of stigma: public, family,
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professional, courtesy and self/internalized stigma. Consensus of these
research was that dementia-related stigma is pervasive, universal and
has negative consequences. Stigmatized attitudes exist with both health
professionals and the lay public [10]. However, the majority of existing
dementia-related stigma research as well as some blogs written by
people living with dementia [13,14] has mostly focused on describing
the subjective experience of stigma [11]. Evaluating ways of reducing
dementia stigmatic beliefs is still lacking. To our knowledge, there is no
existing eﬀective data-driven approach to reducing dementia-related
public stigma (the stereotypes, prejudice, and discriminatory behaviors
held by laypersons toward a person or group with a stigmatized con-
dition) which uses accessible and targeted eﬃcacious interventions.
Yet, this is of extreme importance as public stigma has received a great
deal of interest in the area of dementia in the past decade [15] and it
plays a major role in the formation of other types of stigma such as
courtesy stigma (stigma of those associated with a stigmatized person)
and self or internalized stigma (prejudice that people with the condition
turn against themselves by internalizing the negative attitudes they
perceive from society) [16,17].
The two main stigma reduction strategies that are commonly used in
other widely studied stigmatized conditions are education and contact
[18]. Education involves providing factual information on stigmatizing
conditions to replace inaccurate stereotypes and beliefs, and increasing
aﬃrming attitudes. Contact involves direct or indirect contact with
people with stigmatizing conditions. These approaches however, have
not been tested in the area of dementia in the form of an intervention
study. Previously conducted research were cross-sectional studies and/
or used the experimental vignette methodology to assess the dementia-
related stigmatic beliefs of laypersons [19–23]. Of this, only one
quantitative study was based on a randomized design [20]. These stu-
dies however, suggested that providing education can reduce stigma
[12]. Conversely, there has only been one study that found that parti-
cipation in an intergenerational choir led to a decrease in stigma
amongst college students who had interaction with people with de-
mentia or mild cognitive impairment, and their family members [24].
This study may suggest that contact approach can be an eﬀective way of
reducing dementia-related public stigma. The eﬀectiveness of personal
exposure delivered via online platforms however, has not been in-
vestigated in reducing dementia-related public stigma. This RCT
therefore, investigates the feasibility and short-term eﬃcacy of an on-
line intervention program, Dementia Risk Reduction (DESeRvE), in
public stigma reduction for dementia utilizing diﬀerent approaches.
2. Methods and analysis
2.1. Study setting and design
The education (ED), contact (CT) and the combination of education
and contact (ED + CT) approaches are being compared to an active
control group in the 2 × 2 factorial RCT in dementia-related public
stigma reduction. Internet-delivered intervention is being used as it is
cost-eﬀective and eﬃcient, and it provides the opportunity for large-
scale implementation at the population level compared with more
traditional face-to-face interventions [25].
The study is being conducted nationally in Australia. The trial has
been designed and is being conducted according to the Consolidated
Standards of Reporting Trials (CONSORT) statements for non-pharma-
ceutical trials [26], and will be reported according to the Standard
Protocol Items: Recommendations for Intervention Trials (SPIRIT)
guidelines [27]. Dementia Alliance International and Dementia Aus-
tralia – ACT were on advisory panel for this project.
2.2. Participants
Participants from the general public are currently being recruited by
the survey company, Qualtrics (www.qualtrics.com). We aim to recruit
500 participants and follow them for 12 weeks from baseline. There will
be two follow up assessments (immediately after the completion of the
intervention and at 12 weeks after commencement of the intervention).
An invitation email with a link to the DESeRvE has sent to potential
participants by Qualtrics. Once the interested participants open the
link, an information sheet and a consent form appear before proceeding
to the questionnaire. By clicking “I agree”, participants conﬁrm that
they understand what is provided in the information sheet, that they do
meet all inclusion criteria, no exclusion criteria, and that they agree to
participate in this trial. Baseline assessment collecting all outcomes and
co-variate data has been conducted on the Qualtrics survey platform
prior to intervention and primary and secondary outcome data are
being collected online again at immediate and 12 weeks follow-ups.
Recruitment began in September 2018.
2.3. Inclusion criteria
Participants must be aged 40 years and over, reside in Australia,
have access to a computer and internet connection, and be ﬂuent in
English.
2.4. Exclusion criteria
Participants are not eligible to enroll in the trial if they are diag-
nosed with Alzheimer's disease or other types of dementia. They are
also ineligible if they have visual and/or auditory deﬁcits with regards
to watching video clips.
2.5. Sample size calculations
Sample size calculations were undertaken using G*Power (version
3.1.9.2; http://www.gpower.hhu.de/en.html). To detect a medium ef-
fect size, which was based on the previous Body Brain Life (BBL; Trial
ID: ACTRN12612000147886) [28,29]) study, in one control and three
experimental conditions with a 5% risk of type 1 error (α) and 95%
power, a total sample size of 280 persons is required. We are collecting
500 participants at baseline with a 40% dropout rate in mind at the
follow-up assessment. This rate was provided by Qualtrics based on
their previous experience and statistics on participants coming back for
the follow-up assessment.
2.6. Primary outcome
The primary outcome is the general public's level of stigmatic beliefs
about people with dementia. It is assessed with an adapted version of
the Attribution Questionnaire (AQ) [30], assessing the cognitive,
emotional, and behavioral aspects of public stigma in mental illness
using three items for each dimension. The term “mental illness” is re-
placed with the term “dementia” to suit the topic of the current trial and
9-point Likert scale is replaced with a 5 point Likert scale, as a 9-point
Likert scale has endpoint anchor labels only and the middle values may
have diﬀerent meanings to diﬀerent people. An adapted version of the
AQ with 9-point Likert scale was used in previous research [15] al-
though this scale was not validated with adult participants. A written
vignette describing a person with an early stage of dementia is pre-
sented prior to the questionnaire.
2.7. Secondary outcome
The secondary outcome is dementia knowledge which is being as-
sessed with the Dementia Knowledge Assessment Scale (DKAS) - version
2 [31]. This validated and reliable scale comprises of 25 items con-
sidered important in understanding dementia and associated care
needs.
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2.8. Covariate
Sociodemographic information such as gender (male vs female), age
(at last birthday), years of education, country of birth (Australia, UK,
New Zealand, or others), cultural background (Australian vs others) and
weakly household income are being collected. Participants are also
being asked if they currently know or had known someone with de-
mentia (yes vs no) and whether they are taking or have taken care of
someone with 32dementia (yes vs no).
2.9. Randomization
Upon completion of the baseline assessment, participants are ran-
domly allocated to one of the four groups (see Fig. 1) using a rando-
mization function on the survey platform (Qualtrics). Randomization is
stratiﬁed by gender, age and state as previous study [32] suggested that
dementia-related stigma is age and gender speciﬁc. Randomization by
state is undertaken in order to assist with post hoc subgroup analyses as
dementia support organizations are state based and interest may de-
velop diﬀerently in diﬀerent state.
Participants are not told explicitly which intervention group they
are in. It is likely though, that they are able to infer the group by the
introductory notes on the study. Hence blinding cannot be assured.
2.10. Interventions
2.10.1. Group 1: Education (ED)
For the ED group, an adaptation of the dementia literacy module
from the BBL is being delivered online. The BBL is the ﬁrst online in-
tervention program designed to reduce the risk of developing dementia.
The dementia literacy module was developed and revised after ex-
tensive consumer evaluation by members of the Dementia Australia
Consumer Dementia Research Network as well as members of the
public and from participant feedback after the previous trial. The
module provides information about dementia in terms of deﬁnition,
symptoms, pathology, and treatments. The BBL is written in laypersons
language and is documented to improve dementia literacy in a RCT
[29]. Information on dementia-related stigma and its impacts have been
added to this module. The education intervention takes approximately
20min to complete. However, there is no time limit and participants
are able to complete the module within a week of starting it. BBL tested
feasibility of an online intervention program that utilize both written
and visual (video clips) materials to educate the general public.
2.10.2. Group 2: Contact (CT)
Participants in the CT group watch video clips reﬂecting what it is
like to live with dementia and what it is like to care for someone with
dementia. These video clips were created featuring people with de-
mentia and people supporting someone living with dementia answering
frequently asked questions (FAQ) drawn from a focus group study
conducted with 31 mid and older aged Australians [33]. These ques-
tions were about dementia and about living with dementia (e.g. what is
dementia? How can you best support a person with dementia to
maintain independence? How do you manage a person's need to walk
freely?). To enhance the eﬀects of the contact component, the DESeRvE
program is designed so that participants can choose questions from a
pool of questions (FAQ) about what they would like to learn from
people with dementia or people supporting someone living with de-
mentia. The program then plays relevant pre-recorded video clips in
response to questions. This method is used to make participants feel as
if they are having a virtual conversation with a real person with de-
mentia or people supporting someone living with dementia instead of
receiving a one-way dialogue. It is expected to be at least as eﬀective as
a commonly used video-based contact approach and impact of direct
and indirect contact is expected to be equivalent as found in mental
health stigma reduction studies [34,35]. The participants can ask as
many questions as they wish lasting approximately 20min. As for the
CT group, the CT intervention will be available for a week from the start
of the intervention.
2.10.3. Group 3: Education plus Contact (ED + CT)
The ED + CT group receives materials from both CT and ED groups.
2.10.4. Group 4: Active control/email only
The active control group receives written information related to
general health. It includes a deﬁnition of health, common chronic
conditions, risk factors, and health services. It takes approximately
20min to complete. Participants in this group will have access to ma-
terials from education and contact groups as a means of debrieﬁng at
the end of the intervention.
2.11. Data management
All data are automatically entered into an SPSS ﬁle and stored
electronically. These data ﬁles are only accessible by the researchers
involved in this study.
Fig. 1. Study ﬂow.
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2.12. Statistical analyses
Descriptive statistics will be calculated for the outcome variables
stratiﬁed by gender, age and state. A one-way repeated measures ana-
lysis of variance will be used to determine the diﬀerence between
treatment groups over time. In the event of highly correlated responses
over time, a longitudinal analysis using multilevel model with random
eﬀects will also be ﬁtted to the data. We hypothesize that the level of
dementia-related stigma and dementia knowledge will be reduced and
enhanced respectively for those in the intervention groups more than
those in the Active control group. Intention to treat analysis with
multiple imputation of missing values will be used to compare treat-
ment groups.
2.13. Ethics and trial registration
The Human Research Ethics Committee at the Australian National
University has approved the study protocols and procedures (protocol
#2018/427). This project has also been registered at the Australian
New Zealand Clinical Trials Registry (ACTRN: 12618001136291p).
2.14. Adverse events
The target population is adults aged 40 and older who are free of
any dementia-related symptoms. We do not anticipate that participants
are placed at a greater risk than that associated with self-driven edu-
cational activities over the Internet.
2.15. Dissemination plan
Positive, neutral and negative results of the trial will be submitted to
international peer-reviewed journals. In addition, results will be pre-
sented at national and international conferences relevant to the subject
matters. Authorship will be allocated using the guidelines for author-
ship deﬁned by the International Committees of Medical Journal
Editors and will depend on individual involvement.
3. Discussion
Given the negative eﬀects stigma has on people living with de-
mentia, and people supporting someone with dementia as well as on the
delivery of timely diagnosis and management, there is a need for an
eﬀective program to reduce dementia-related public stigma. This pro-
ject is currently underway as an evaluation of the short-term eﬃcacy of
the Dementia Risk Reduction (DESeRvE) program involving three dif-
ferent approaches, in public stigma reduction for dementia using a RCT.
The program also aims to enhance dementia knowledge. We anticipate
that all data collection will be completed by December 2018.
The results of the study are likely to form an evidence base for the
feasibility of dementia-related stigma campaigns to educate the general
public. If successful, DESeRvE can provide a versatile, evidence-based
program that can be easily and quickly rolled out in the population.
Healthcare providers, workplaces and retirement villages will also be
able to use this intervention to educate their clients, employees and
residents about dementia and reduce dementia-related stigma. This
intervention program will be available to policymakers providing them
with a method of reducing dementia-related stigma in areas where it
presents a barrier to help-seeking and timely diagnosis and reduces the
quality of life. In addition, successful outcomes of the current trial may
lead to more people seeking help as soon as they display dementia
symptoms, which will have major beneﬁts to individuals and their fa-
milies.
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